Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
SRNE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 0.58%575.732.7%$668.74m
AMGNAmgen, Inc. -0.43%227.981.3%$584.64m
ILMNIllumina, Inc. 2.54%325.923.5%$569.57m
ARRYArray BioPharma Inc. 11.69%43.9414.2%$534.29m
GILDGilead Sciences, Inc. 0.76%60.671.0%$505.18m
MRNAModerna, Inc. 3.61%70.840.0%$488.77m
VRTXVertex Pharmaceuticals, Inc. -0.62%210.081.9%$485.35m
IMMUImmunomedics, Inc. 0.05%87.8611.0%$373.44m
NVAXNovavax, Inc. 2.67%93.5996.5%$310.87m
ALXNAlexion Pharmaceuticals, Inc. 1.25%119.672.0%$283.93m
BIIBBiogen, Inc. -0.79%266.801.6%$262.52m
EXASEXACT Sciences Corp. 7.51%107.0920.7%$236.03m
BNTXBioNTech SE -1.55%86.360.0%$211.34m
SRNESorrento Therapeutics, Inc. 5.48%8.281.4%$191.26m
SGENSeagen Inc. 1.49%200.666.0%$164.79m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.